Einstein Visiting Fellow
The aim of the "Einstein Visiting Fellow" funding program of the Einstein Foundation is to integrate top foreign scientists into the Berlin research landscape in order to further strengthen the international profile of the Berlin universities and research facilities for the future.
A particular target group consists of those researchers who can add special expertise to the focus areas of science in Berlin but cannot be gained through the conventional appointment route because they are bound to their home universities.
Each year a maximum of 150,000 € per Einstein Visiting Fellow is made available by the Einstein Foundation. This funding can be applied flexibly by the scientists for their research.
For further information on the Einstein Foundation click here.
Prof. Dr. Roger Traub has been a "Visiting Fellow" within the framework of the Einstein Foundation Berlin since December 2010. He studied mathematics at Princeton University and completed his medical studies at the University of Pennsylvania.
Since 2001, Roger Traub has been Professor for Physiology, Pharmacology and Neurology at the State University New York. In addition, he works as a research member for IBM at the Watson Research Center.
Roger Traub is an expert in the computer simulation of circuits between cortical neurons, which are used, for example, in epilepsy research.
In cooperation with the working groups of Prof. Dr. Dietmar Schmitz and Prof. Dr. Michael Brecht, Roger Traub researches rapid network oscillations and intracellular spikes and spikelets both in vitro and in vivo. Due to Traub's realistic simulations, characteristic, verifiable predictions can now be made. This enables NeuroCure scientists to carry out deeper analyses on even cryptic experimental observations.
NeuroCure Visiting Fellows
Following the model of the "Visiting Fellow“ program of the Einstein Foundation Berlin, NeuroCure also finances three renowned foreign scientists. These researchers are incorporated into the research of the cluster over the long term and contribute through new ideas to synergies and international networking. Visiting fellows are required to be present in Berlin several times a year for a longer period of time and participate actively in the research and teaching activities of the cluster. This can take the form of, e.g., joint projects, the development of new technologies or scientific lectures as a supplement to teaching.
Annual funding of 50,000 € is available to NeuroCure Visiting Fellows for three years and can be applied flexibly by the scientists.
Prof. Dr. Burkhard Becher has been a NeuroCure Visiting Fellow since January 2011. He works in the laboratory of Prof. Dr. Frank Heppner at the Charité Institute for Neuropathology.
Burkhard Becher is the Deputy Director of the Institute for Experimental Immunology at the University Hospital Zurich. After completing studies in biology in Cologne, he completed a PhD in microbiology and immunology at McGill University in Montreal, Canada.
His main interest is in researching pathogenesis mechanisms that lead to the occurrence of diseases of the central nervous system. His working group works primarily with in vivo animal models to analyze degenerative, malign and inflammatory processes. Burkhard Becher is especially interested in the role and function of inborn and adaptive immune defenses during the development of degenerative diseases and their repair mechanisms and tumor immunology within the central nervous system.
Prof. Dr. Brian MacVicar has been a NeuroCure Visiting Fellow since March 2011. He works in the laboratory of Prof. Dr. Helmut Kettenmann at the Max-Delbrück Center for Molecular Medicine (MDC).
Brian MacVicar studied zoology and neurophysiology at the University of Toronto. He is now a professor in the Department of Psychiatry at the Brain Research Centre of the University of British Columbia, Canada. He is also President of the Canadian Association for Neuroscience.
The working group of Brian MacVicar carries out research on the physiology of glial cells, the interaction of nerve cells with glial cells, and astrocyte vessel interactions. He was the first scientist to describe voltage-controlled Ca2+ channels in astrocytes. His group also showed that gap junction hemichannels open during stroke.
Prof. Dr. Istvan Mody has been a NeuroCure Visiting Fellow since March 2011. He works in the laboratory of Prof. Dr. Uwe Heinemann at the Charité Institute for Neurophysiology.
Istvan Mody studied physiology with a special focus on neurophysiology at the University of British Columbia in Vancouver, Canada. Since 1995 he has held a Tony Coelho Professorship for Neurology and Physiology at the UCLA School of Medicine, California. Istvan Mody was also recipient of an Izaak Walton Killam Memorial Postdoctoral Fellowship at the Max Planck Institute of Psychiatry in Munich.
His working group conducts research into GABA channels and epilepsy.